SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
OSI Pharmaceuticals (OSIP) - formerly Oncogene
An SI Board Since December 1997
Posts SubjectMarks Bans Symbol
447 40 0 OSIP
Emcee:  James Reynolds Type:  Unmoderated
Introduction Market Data Compact
Anyone still following this Company?
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
447OSIP Insider buying at $34 OSIP Osi Pharmaceuticals Inc Klein Joseph jeeee4-1/25/2010
446Message 25341382 SLV320 lives.scaram(o)uche-1/20/2009
445Merrill Tarceva expansion still key to growth, pipeline is long-term The R&tom pope-12/5/2008
444medscape.com Improved Renal Function and Modest Hemodynamic Changes With Adenosscaram(o)uche-10/17/2008
443Goddard: Message 25026547 The reasons for your strange behavior re. the Cadus scaram(o)uche-10/4/2008
442Message 25006829scaram(o)uche-9/29/2008
441OSI'S WARNING: OSI Pharmaceuticals, Genentech Add New Warnings To Tarceva Afmlkr-9/24/2008
440But Goddard keeps pushing money out for the Cadus license..... OSI shareholdersscaram(o)uche-5/15/2008
439I remember looking in a 10K a few years ago, and seeing some, but not all, of thtuck-5/7/2008
438Thanks. JonRobohogs-1/14/2008
437Jon: SLV320 from Solvay, purchased by OSI from Cadus (verification from Solvay scaram(o)uche-1/14/2008
436A) and C) only.DewDiligence_on_SI-1/13/2008
435Which one? JonRobohogs-1/13/2008
4341. Why would a biotech CEO suddenly stop talking about the progress of a partnescaram(o)uche-1/11/2008
433OSI molecule moves back into phase II testing, huge market..... clinicaltrials.scaram(o)uche-1/7/2008
432Message 24190118scaram(o)uche-1/7/2008
431Goddard’s epitaph… [graphic]DewDiligence_on_SI-7/31/2007
430Merrill: Raising estimates on strong execution OSIP raised full-year GAAP EPS tom pope-7/31/2007
429They recognized .06/sh of income for terminating the healthcare coverage of retiDewDiligence_on_SI-7/30/2007
428I hear that. But even with the Eyetech biz on the books, OSIP beat by 4 cent, atuck-7/30/2007
427Goddard, LOL: siliconinvestor.comDewDiligence_on_SI-7/30/2007
426OSI actually manages to offload the Eyetech stuff --or at least some of it -- butuck-7/27/2007
425Goddard: Any comments? Message 23734098 Rickscaram(o)uche-7/26/2007
424This is from ML a couple of days ago which I didn't crib because there didn&tom pope-7/25/2007
423The grapevine has it that Roche's competing program in glucokinase activatiotuck-7/25/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News